ScienceDex / Researcher record
Quong, Andrew
- Fluidigm Corporation (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 5% Funded
- Early Career
NIH Funding · FY2021
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2021): $8.6M in linked award amounts across 1 award record · Award-linked rank #311.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Quong, Andrew as a PI. Multi-PI records show the full award amount for context.
- 75N92020C00009-P00002-9999-1N02Contact PIRADX PROGRAM: TECH PROJECT NO 6114 FLUIDIGM ADVANTA DX SARS-COV-2 RT-PCR ASSAY FOR SALIVA$8.6Maward amount
Award organization
Organizations that administered FY2021 awards listing Quong, Andrew as a PI.
FY2021 award administered by Fluidigm Corporation ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardFluidigm Corporation
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #311
- 2021Entered Top 25% NationallyRanked #311
- 2021Entered Top 10% NationallyRanked #311
- 2021Entered Top 5% NationallyRanked #311